+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Alkem Laboratories Ltd (ALKEM) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 49 Pages
  • August 2023
  • GlobalData
  • ID: 4391482
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Alkem Laboratories Ltd (ALKEM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Alkem Laboratories Ltd (Alkem) develops, manufactures and markets generic and specialty pharmaceutical products. The company's product portfolio includes active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides drugs for acute and chronic diseases such as central nervous system disorders, gastro-intestinal infections, metabolic disorders and diabetes, cancer, skin and hair diseases, urologic diseases, cardiovascular diseases, immune disorders and pain relief. It also offers vitamins, minerals and nutrition products. The company distributes its products directly through its subsidiaries or through a wide network of distributors over more than 40 countries. It also exports products to Germany, Australia, South-East Asia, the US, the UK, Russia-CIS, and Africa. Alkem is headquartered in Mumbai, Maharashtra, India.

Alkem Laboratories Ltd Key Recent Developments

  • May 19, 2023: Alkem Laboratories announces audited financial results for the quarter and year ended 31 March 2023
  • May 19, 2023: Alkem Laboratories announces 49 annual general meeting
  • Nov 11, 2022: Alkem Laboratories Announces Financial Results For Quarter Ended September 30, 2022
  • Sep 15, 2022: Alkem : US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Alkem Laboratories Ltd - Key Facts
  • Alkem Laboratories Ltd - Key Employees
  • Alkem Laboratories Ltd - Key Employee Biographies
  • Alkem Laboratories Ltd - Major Products and Services
  • Alkem Laboratories Ltd - History
  • Alkem Laboratories Ltd - Company Statement
  • Alkem Laboratories Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Alkem Laboratories Ltd - Business Description
  • Geographical Segment: Domestic
  • Performance
  • Geographical Segment: Other Countries
  • Performance
  • Geographical Segment: United States of America
  • Performance
  • R&D Overview
  • Alkem Laboratories Ltd - Corporate Strategy
  • Alkem Laboratories Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Alkem Laboratories Ltd - Strengths
  • Alkem Laboratories Ltd - Weaknesses
  • Alkem Laboratories Ltd - Opportunities
  • Alkem Laboratories Ltd - Threats
  • Alkem Laboratories Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Alkem Laboratories Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 19, 2023: Alkem Laboratories announces audited financial results for the quarter and year ended 31 March 2023
  • May 19, 2023: Alkem Laboratories announces 49 annual general meeting
  • Nov 11, 2022: Alkem Laboratories Announces Financial Results For Quarter Ended September 30, 2022
  • Sep 15, 2022: Alkem : US FDA Inspection at Alkem’s manufacturing facility located at St. Louis, USA
  • Aug 05, 2022: Alkem Laboratories Announces Unaudited Consolidated & Standalone Financial Results for the Quarter Ended 30 June 2022
  • Jul 26, 2022: Alkem Laboratories Invites to Q1FY23 Conference Call on August 5, 2022
  • Jul 07, 2022: US FDA Inspection at Alkem’s manufacturing facility located at Indore
  • Jun 18, 2022: US FDA Inspection at manufacturing facility of Alkem located at St. Louis, USA
  • May 13, 2022: Alkem Laboratories announces MHRA inspection at Bioequivalence Center
  • May 02, 2022: Alkem Laboratories Invite for O4FY22 and FY22 Conference Call at 4:00 pm IST,May 13, 2022
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Alkem Laboratories Ltd, Key Facts
  • Alkem Laboratories Ltd, Key Employees
  • Alkem Laboratories Ltd, Key Employee Biographies
  • Alkem Laboratories Ltd, Major Products and Services
  • Alkem Laboratories Ltd, History
  • Alkem Laboratories Ltd, Subsidiaries
  • Alkem Laboratories Ltd, Key Competitors
  • Alkem Laboratories Ltd, Ratios based on current share price
  • Alkem Laboratories Ltd, Annual Ratios
  • Alkem Laboratories Ltd, Interim Ratios
  • Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Alkem Laboratories Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Alkem Laboratories Ltd, Performance Chart (2019 - 2023)
  • Alkem Laboratories Ltd, Ratio Charts
  • Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Symed Laboratories Ltd
  • Natco Pharma Ltd
  • Lupin Ltd
  • Sun Pharmaceutical Industries Ltd
  • Harshvardhan's Laboratories Pvt Ltd
  • Biocon Ltd
  • Aurobindo Pharma Ltd
  • Lipicard Technologies Ltd
  • Dr. Reddy's Laboratories Ltd
  • Intas Pharmaceuticals Ltd
  • Cipla Ltd
  • Brawn Laboratories Ltd
  • Amsal Chem Pvt Ltd
  • Panvo Organics Pvt Ltd
  • Sun Pharmaceutical Industries Ltd
  • Dr. Reddy's Laboratories Ltd
  • Lipicard Technologies Ltd
  • Symed Laboratories Ltd
  • Symbiotec Pharma Lab Pvt Ltd
  • Lupin Ltd
  • Cipla Ltd
  • Brawn Laboratories Ltd
  • Panvo Organics Pvt Ltd
  • Intas Pharmaceuticals Ltd
  • Amsal Chem Pvt Ltd
  • Harshvardhan's Laboratories Pvt Ltd
  • Biocon Ltd
  • Aurobindo Pharma Ltd
  • Natco Pharma Ltd